- Home
- VSTM vs PSBD Comparison
VSTM vs PSBD Comparison
Compare VSTM & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$6.95
Company Overview
Basic Information| Metric | VSTM | PSBD |
|---|---|---|
| Founded | 2010 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.4M | 325.5M |
| IPO Year | 2011 | 2019 |
Fundamental Metrics
Financial Performance| Metric | VSTM | PSBD |
|---|---|---|
| Price | $6.95 | $10.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 9 |
| Target Price | ★ $16.50 | $12.33 |
| AVG Volume (30 Days) | ★ 2.2M | 113.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 15.02% |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ 1.66 |
| Revenue | ★ $30,914,000.00 | N/A |
| Revenue This Year | $282.64 | N/A |
| Revenue Next Year | $72.25 | N/A |
| P/E Ratio | ★ N/A | $6.30 |
| Revenue Growth | ★ 209.14 | N/A |
| 52 Week Low | $3.43 | $9.34 |
| 52 Week High | $11.25 | $14.43 |
Technical Indicators
Market Signals| Indicator | VSTM | PSBD |
|---|---|---|
| Relative Strength Index (RSI) | 71.43 | 60.20 |
| Support Level | $6.68 | $10.32 |
| Resistance Level | $7.05 | $11.08 |
| Average True Range (ATR) | 0.42 | 0.32 |
| MACD | 0.06 | 0.12 |
| Stochastic Oscillator | 86.94 | 89.50 |
Price Performance
Historical Comparison VSTM
PSBD
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About PSBD Palmer Square Capital BDC Inc.
Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.